Ładuje się......
Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy
Immunotherapy with checkpoint inhibitors has revolutionized cancer therapy and is now the standard treatment for several different types of cancer, supported by favorable outcomes and good tolerance. However, it is linked to multiple immune manifestations, referred to as immune-related adverse event...
Zapisane w:
| Wydane w: | Gastroenterol Rep (Oxf) |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Oxford University Press
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7034236/ https://ncbi.nlm.nih.gov/pubmed/32104583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goz065 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|